The treatment of coronary de novo lesions with ELUTAX-SV Paclitaxel-eluting balloon alone, a pilot study (EXPEL), Dr. S. Eggert Jensen, Aalborg, Dänemark.
Drug eluting balloon efficacy for small vessel disease treatment, B. Cortese, Mailand, Italien.
Swedish drug-eluting trial in peripheral arterial disease (SWEDEPAD), Schweden.
Evaluation of stents versus drug-eluting balloon ELUTAX-SV versus DEB with additional stenting for the treatment of below the knee- critical limb ischemia: a prospective trial.
A prospective observational study using ELUTAX-SV drug-eluting balloons for below the knee treatment (APOLLO), Dr. Teichgräber, Jena, Deutschland.
Polish registry angioplasty of infrainguinal arteries using DEB (ELUTAX-SV) – progress.
Swiss registry with ELUTAX-SV treatment of patients with de novo stenosis or restenosis in a peripheral vessel with ELUTAX-SV 3rd generation.
Iranian post market register with ELUTAX-SV, controlled use of DEB in coronary arteries – a multicenter study, since 2012, Iran.
Drug-eluting balloon in restenosis of drug-eluting stents: medium term follow-up.
DEB in treatment of CLI – single center experience, SUSCCH Banska Bystrica, Slowakei.
Clinical evidence of ELUTAX-SV in critical limb ischemia, Dr. R. Zahorsky, Hamburg, Deutschland.
ELUTAX-SV DEB use in hemodialysis fistulas and grafts, Prag, Tschechien.
Efficacy of the treatment of recurrent stenosis of vascular access with a drug-eluting balloon, Parma, Italien.
Treating recurrent stenosis in native AV fistulae using the ELUTAX DEB, Northhampton, UK.
Asian ELUTAX-SV (DCB) for intracranial stenosis trial.
Analysis of the performance of N-ELUTAX-SV in patients with intracranial stenosis treated in the participating center, Alfred Krupp Krankenhaus, Essen.
Neuro-ELUTAX-SV in supra-aortic vessels: first results and follow-up, H. Deutschmann, Graz, Österreich.
D’Amico, M. and Pennone M., Drug eluting balloon in restenosis of drug-eluting stent: medium term follow up, 2013, Turin, Italien.
Cortese, B. et al. (2015): “TCT-417 treatment of coronary artery disease with a new-generation drug coated balloon: preliminary results from the Italian ELUTAX-SV registry”.
Cortese, B. et al. (2015): “Effect of drug-coated balloons in native coronary artery disease left with a dissection”.
Liistro, F. Porto, I. et al. (2013): “ELUTAX paclitaxel-eluting balloon followed by bare metal stent compared with Xience V drug-eluting stent in the treatment of de novo coronary stenosis: a randomized trial”.
Ulf Teichgräber et.al (2019): Drug-Coated Balloon Angioplasty of Infrapopliteal Lesions in Patients with Critical Limb Ischaemia: 1-Year Results of the APOLLO Trial .
Philip Gruber et.al. (2018): Neuro Elutax SV drug-eluting balloon versus Wingspan stent system in symptomatic intracranial high-grade stenosis: a single-center experience .
Tolva, V., et al. (2016): “The mid-term clinical follow-up using drug-eluting balloons on tibial artery de novo lesions in patients with critical limb ischemia: a cohort study”.
Massmann, A. et al. (2015): “Paclitaxel-coated balloon angioplasty for symptomatic central vein restenosis in patients with hemodialysis fistulas".